CA2524921A1 - Method and composition for treating burned skin - Google Patents
Method and composition for treating burned skin Download PDFInfo
- Publication number
- CA2524921A1 CA2524921A1 CA002524921A CA2524921A CA2524921A1 CA 2524921 A1 CA2524921 A1 CA 2524921A1 CA 002524921 A CA002524921 A CA 002524921A CA 2524921 A CA2524921 A CA 2524921A CA 2524921 A1 CA2524921 A1 CA 2524921A1
- Authority
- CA
- Canada
- Prior art keywords
- indomethacin
- skin
- mixture
- moisturizing lotion
- steps
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 53
- 238000000034 method Methods 0.000 title claims abstract description 28
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 claims abstract description 73
- 229960000905 indomethacin Drugs 0.000 claims abstract description 36
- 239000006210 lotion Substances 0.000 claims abstract description 25
- 230000003020 moisturizing effect Effects 0.000 claims abstract description 25
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 12
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims abstract description 12
- KANINNSSRWMGIP-UHFFFAOYSA-M sodium;butyl 4-hydroxybenzoate;dodecyl sulfate;hexadecan-1-ol;methyl 4-hydroxybenzoate;octadecan-1-ol;propane-1,2-diol;propyl 4-hydroxybenzoate Chemical compound [Na+].CC(O)CO.COC(=O)C1=CC=C(O)C=C1.CCCOC(=O)C1=CC=C(O)C=C1.CCCCOC(=O)C1=CC=C(O)C=C1.CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCOS([O-])(=O)=O.CCCCCCCCCCCCCCCCCCO KANINNSSRWMGIP-UHFFFAOYSA-M 0.000 claims abstract description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000001959 radiotherapy Methods 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 5
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 claims abstract description 4
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 claims abstract description 4
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims abstract description 4
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims abstract description 4
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims abstract description 4
- 235000018330 Macadamia integrifolia Nutrition 0.000 claims abstract description 4
- 240000000912 Macadamia tetraphylla Species 0.000 claims abstract description 4
- 235000003800 Macadamia tetraphylla Nutrition 0.000 claims abstract description 4
- 150000001252 acrylic acid derivatives Chemical class 0.000 claims abstract description 4
- 229940081733 cetearyl alcohol Drugs 0.000 claims abstract description 4
- 229920006037 cross link polymer Polymers 0.000 claims abstract description 4
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229940008099 dimethicone Drugs 0.000 claims abstract description 4
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims abstract description 4
- 239000004205 dimethyl polysiloxane Substances 0.000 claims abstract description 4
- 229940043259 farnesol Drugs 0.000 claims abstract description 4
- 229930002886 farnesol Natural products 0.000 claims abstract description 4
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 claims abstract description 4
- 235000011187 glycerol Nutrition 0.000 claims abstract description 4
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 claims abstract description 4
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000010466 nut oil Substances 0.000 claims abstract description 4
- 229940101267 panthenol Drugs 0.000 claims abstract description 4
- 235000020957 pantothenol Nutrition 0.000 claims abstract description 4
- 239000011619 pantothenol Substances 0.000 claims abstract description 4
- 229960005323 phenoxyethanol Drugs 0.000 claims abstract description 4
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 claims abstract description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims abstract description 4
- 239000008213 purified water Substances 0.000 claims abstract description 4
- 229940012831 stearyl alcohol Drugs 0.000 claims abstract description 4
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 claims abstract description 4
- GVPDNFYOFKBFEN-UHFFFAOYSA-N trimethyl(octadecoxy)silane Chemical compound CCCCCCCCCCCCCCCCCCO[Si](C)(C)C GVPDNFYOFKBFEN-UHFFFAOYSA-N 0.000 claims abstract description 4
- 125000005250 alkyl acrylate group Chemical group 0.000 claims abstract description 3
- 229940073669 ceteareth 20 Drugs 0.000 claims abstract description 3
- 239000004615 ingredient Substances 0.000 claims abstract description 3
- 239000003974 emollient agent Substances 0.000 claims description 3
- 239000003906 humectant Substances 0.000 claims description 3
- 231100000075 skin burn Toxicity 0.000 abstract description 6
- 230000006641 stabilisation Effects 0.000 abstract 1
- 238000011105 stabilization Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 19
- 206010042496 Sunburn Diseases 0.000 description 16
- 230000036407 pain Effects 0.000 description 9
- 239000006071 cream Substances 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- 206010061218 Inflammation Diseases 0.000 description 6
- 230000004054 inflammatory process Effects 0.000 description 6
- 230000000699 topical effect Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 239000002674 ointment Substances 0.000 description 4
- 206010006797 Burns first degree Diseases 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000027866 inflammatory disease Diseases 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 206010033372 Pain and discomfort Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010063562 Radiation skin injury Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000035597 cooling sensation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 229940072709 motrin Drugs 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 229940099261 silvadene Drugs 0.000 description 1
- 229960003600 silver sulfadiazine Drugs 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- -1 steroid chemical compound Chemical class 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000000015 thermotherapy Methods 0.000 description 1
- UPSPUYADGBWSHF-UHFFFAOYSA-N tolmetin Chemical compound C1=CC(C)=CC=C1C(=O)C1=CC=C(CC(O)=O)N1C UPSPUYADGBWSHF-UHFFFAOYSA-N 0.000 description 1
- 239000012049 topical pharmaceutical composition Substances 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/636,404 US7714015B2 (en) | 2003-08-07 | 2003-08-07 | Method and composition for treating sunburned skin |
| US10/636,404 | 2003-08-07 | ||
| PCT/US2004/025260 WO2005016336A1 (en) | 2003-08-07 | 2004-08-05 | Method and composition for treating burned skin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2524921A1 true CA2524921A1 (en) | 2005-02-24 |
Family
ID=34116419
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002524921A Abandoned CA2524921A1 (en) | 2003-08-07 | 2004-08-05 | Method and composition for treating burned skin |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7714015B2 (enExample) |
| EP (1) | EP1656135A1 (enExample) |
| JP (1) | JP4890250B2 (enExample) |
| KR (1) | KR20060037428A (enExample) |
| AU (1) | AU2004264332B2 (enExample) |
| CA (1) | CA2524921A1 (enExample) |
| WO (1) | WO2005016336A1 (enExample) |
| ZA (1) | ZA200601054B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1863437B1 (de) * | 2005-03-24 | 2014-02-26 | Beiersdorf Ag | Verwendung von zubereitungen zum schutz hauteigener enzyme |
| WO2008115656A1 (en) * | 2007-02-22 | 2008-09-25 | Healing Skin Llc | Novel burn treatment composition |
| US20090107925A1 (en) * | 2007-10-31 | 2009-04-30 | Chevron U.S.A. Inc. | Apparatus and process for treating an aqueous solution containing biological contaminants |
| US8349764B2 (en) | 2007-10-31 | 2013-01-08 | Molycorp Minerals, Llc | Composition for treating a fluid |
| KR101985886B1 (ko) * | 2013-06-24 | 2019-06-04 | 주식회사 엘지생활건강 | 인돌 화합물 및 판테놀을 포함하는 자외선에 의한 피부손상 예방 및 개선용 조성물 |
| US12280144B2 (en) | 2019-12-19 | 2025-04-22 | Zaki Yusuf | Gel compositions for mitigation of burn injuries, kits containing the gel compositions, and associated methods |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US493362A (en) * | 1893-03-14 | Check-row corn-planter | ||
| US3629412A (en) | 1969-09-19 | 1971-12-21 | Merck & Co Inc | Topical anti-inflammatory agent |
| US4088754A (en) * | 1976-03-02 | 1978-05-09 | Research Corporation | Water-soluble cerium (cerous) salts in burn therapy |
| GB2023000B (en) | 1978-06-17 | 1982-10-13 | Kowa Co | Antinflammatory analgesic gelled ointments |
| US4954487A (en) * | 1979-01-08 | 1990-09-04 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions |
| HU185926B (en) | 1979-09-27 | 1985-04-28 | Agostne Kahan | Process for preparing water soluble derivatives of non-steroid antiinflammatory compositions and pharmaceutical compositins containing such derivatives |
| US4384000A (en) * | 1980-08-07 | 1983-05-17 | Lanier Earl W | Method for treatment of various dermatological conditions |
| JPS57165313A (en) * | 1981-04-07 | 1982-10-12 | Nichibei Zoki Kk | Indomethacin for external use |
| US4847283A (en) | 1983-01-10 | 1989-07-11 | Harendza Harinxma Alfred J | Ointment and method for treating skin lesions due to herpes virus |
| US4732755A (en) * | 1983-01-17 | 1988-03-22 | University Of Health Sciences/The Chicago Medical School | Skin burn treatment |
| CH643138A5 (de) | 1983-08-29 | 1984-05-30 | Mepha Ag | Indomethacin enthaltende, gelartige salbe. |
| JPS60105613A (ja) * | 1983-11-15 | 1985-06-11 | Mitsubishi Chem Ind Ltd | インドメタシン外用剤 |
| DE3808039A1 (de) * | 1988-03-10 | 1989-09-21 | Bauer Johann | Kombinationspraeparat, insbesondere zur behandlung von entzuendlichen prozessen |
| US4933362A (en) | 1989-06-06 | 1990-06-12 | Jack Loomstein | Sunburn treatment composition |
| US5674912A (en) * | 1991-03-01 | 1997-10-07 | Warner-Lambert Company | Sunscreen-wound healing compositions and methods for preparing and using same |
| ES2034891B1 (es) * | 1991-08-08 | 1993-12-16 | Cusi Lab | Procedimiento de elaboracion en continuo de sistemas coloidales dispersos, en forma de nanocapsulas o nanoparticulas. |
| DE69430917T2 (de) * | 1993-05-19 | 2003-03-20 | Hisamitsu Pharmaceutical Co | 3-l-MENTHOXY-PROPANE-1, 2-DIOL ALS LÖSUNGSVERMITTLER UND EXTERNE ZUBEREITUNG, DIE DIESEN ENTHÄLT |
| US5807569A (en) | 1993-05-27 | 1998-09-15 | Smithkline Beecham P.L.C. | Topical composition |
| US5558914A (en) | 1994-04-11 | 1996-09-24 | Water-Jel Technologies, Inc. | Water-based formulation for the treatment of sunburn |
| JP2723473B2 (ja) * | 1994-09-22 | 1998-03-09 | ブーク メデイテツク エイ／エス | 硫酸化糖類の用途 |
| CN1102852C (zh) * | 1995-11-13 | 2003-03-12 | 皮特迈国际有限公司 | 含一氧化二氮的止痛药、消炎药和解热药的给药介质及含有这样的介质和药物的药物组合物 |
| US6337320B1 (en) | 1996-10-11 | 2002-01-08 | Thione International, Inc. | Reparatives for ultraviolet radiation skin damage |
| US20010055599A1 (en) | 1997-05-23 | 2001-12-27 | Paul Joseph Drzewiecki | Compositions containing select liquid polyol fatty acid polyesters |
| AUPP229598A0 (en) * | 1998-03-11 | 1998-04-09 | Oldfield Family Holdings Pty Limited | Treatment of sunburn |
| US6274627B1 (en) | 1999-10-12 | 2001-08-14 | Medinox, Inc. | Conjugates of dithiocarbamate disulfides with pharmacologically active agents and uses therefor |
| US6399651B1 (en) * | 2000-06-29 | 2002-06-04 | L. Dean Parks | Method of treating dermatoses using avermectin compound |
| AU8466501A (en) * | 2000-07-21 | 2002-02-05 | Essentia Biosystems Inc | Multi-component biological transport systems |
| US20020143047A1 (en) | 2001-01-05 | 2002-10-03 | Galer Bradley S. | Methods for treating indomethacin responsive headaches |
-
2003
- 2003-08-07 US US10/636,404 patent/US7714015B2/en not_active Expired - Fee Related
-
2004
- 2004-08-04 US US10/911,003 patent/US7705032B2/en not_active Expired - Fee Related
- 2004-08-05 KR KR1020067002636A patent/KR20060037428A/ko not_active Abandoned
- 2004-08-05 JP JP2006522711A patent/JP4890250B2/ja not_active Expired - Fee Related
- 2004-08-05 WO PCT/US2004/025260 patent/WO2005016336A1/en not_active Ceased
- 2004-08-05 CA CA002524921A patent/CA2524921A1/en not_active Abandoned
- 2004-08-05 EP EP04780150A patent/EP1656135A1/en not_active Withdrawn
- 2004-08-05 AU AU2004264332A patent/AU2004264332B2/en not_active Ceased
-
2006
- 2006-02-06 ZA ZA200601054A patent/ZA200601054B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US7714015B2 (en) | 2010-05-11 |
| JP4890250B2 (ja) | 2012-03-07 |
| US20050032877A1 (en) | 2005-02-10 |
| ZA200601054B (en) | 2007-05-30 |
| US7705032B2 (en) | 2010-04-27 |
| AU2004264332A1 (en) | 2005-02-24 |
| WO2005016336A1 (en) | 2005-02-24 |
| AU2004264332B2 (en) | 2010-09-30 |
| KR20060037428A (ko) | 2006-05-03 |
| US20050031555A1 (en) | 2005-02-10 |
| JP2007501792A (ja) | 2007-02-01 |
| EP1656135A1 (en) | 2006-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4285934A (en) | Treatment for herpes virus | |
| DK2512240T3 (en) | Methods and compositions for the treatment and improvement of trigeminal autonomic cephalgias, migraines and vascular conditions | |
| CN108853312B (zh) | 聚桂醇外用凝胶及其制备方法 | |
| EP0592569A1 (en) | Composition and method for transdermal delivery of diclofenac | |
| JPH01151522A (ja) | 皮膚疾患の局所治療 | |
| JPH07504657A (ja) | 局所芳香放出組成物 | |
| JP2015038119A (ja) | 有益な効果を奏するアルギニンの送達 | |
| KR20110074513A (ko) | 피부 감염의 국소 치료법 | |
| EP0759746B1 (en) | A medicated wipe | |
| EP3713583A1 (en) | Methods and compositions for treatment of skin | |
| JPH0585523B2 (enExample) | ||
| CA2160874C (en) | Nasal aromatic releasing compositions | |
| CN113924084A (zh) | 药物组合物 | |
| US7705032B2 (en) | Method and composition for treating burned skin | |
| US6562326B1 (en) | Topical composition for burn healing | |
| JP4256125B2 (ja) | 外用組成物 | |
| US20030072828A1 (en) | Natural therapeutic composition for the treatment of wounds and sores | |
| US11642328B2 (en) | Creatine, its derivatives, compositions and methods of use thereof | |
| US20060216359A1 (en) | Topical preparation for treating ulcerations on the inside of the month | |
| JP2001163783A (ja) | 皮膚疾患治療用外用剤 | |
| US20070141167A1 (en) | Use of Benzyl Nicotinate for Pain Relief | |
| JP2007308403A (ja) | 皮膚外用剤 | |
| EP3890730A1 (en) | Compositions for use in the treatment of photosensitivity | |
| GR1009906B (el) | Παστα για την προληψη και θεραπεια των κατακλισεων και συναφων ελκων και μεθοδος παραγωγης της | |
| HU224882B1 (hu) | Fájdalomcsillapító, gyulladásgátló és izomlazító kenõcs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |